{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:40:17Z","timestamp":1769582417998,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ahj.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T11:49:09Z","timestamp":1552304949000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design"],"prefix":"10.1016","volume":"212","author":[{"given":"Mark","family":"Loeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Dokainish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Dans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia M.","family":"Palileo-Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambuj","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilu","family":"Karaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fastone","family":"Goma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid F.","family":"AlHabib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Yonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Mondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Almahmeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Al Mulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.02.009_bb0005","series-title":"Causes of death","year":"2008"},{"key":"10.1016\/j.ahj.2019.02.009_bb0010","series-title":"Morality, Summary List of Causes","author":"Statistics Canada","year":"2008"},{"key":"10.1016\/j.ahj.2019.02.009_bb0015","unstructured":"Tracking Heart Disease and Stroke in Canada. Released June 2009."},{"issue":"9","key":"10.1016\/j.ahj.2019.02.009_bb0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2006.10.059","article-title":"Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET","volume":"49","author":"Remme","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2019.02.009_bb0030","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.02.009_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2019.02.009_bb0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.02.009_bb0045","doi-asserted-by":"crossref","first-page":"11I","DOI":"10.1016\/S0002-9149(97)00793-5","article-title":"Role of endothelial dysfunction in coronary artery disease and implications for therapy","volume":"80","author":"Kinlay","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1814-2","DOI":"10.1016\/S0735-1097(01)01669-2","article-title":"Cardiovascular risk factors as determinants of endothelium-dependent and endotheliumindependent vascular reactivity in the general population","volume":"38","author":"Chan","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJM199705013361809","article-title":"The composition of coronary-artery plaques","volume":"336","author":"Davies","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl. A","key":"10.1016\/j.ahj.2019.02.009_bb0060","first-page":"260A","article-title":"Chlamydia pneumonia-induced transactivation of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis","volume":"33","author":"Zhou","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/clc.4960161103","article-title":"Vascular events responsible for thrombotic occlusion of a blood vessel","volume":"16","author":"Conti","year":"1993","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0070","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1161\/01.CIR.96.10.3266","article-title":"Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease","volume":"96","author":"Lundman","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.02.009_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0735-1097(99)00168-0","article-title":"Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery","volume":"34","author":"Kawano","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2019.02.009_bb0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2010.12.017","article-title":"The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study","volume":"29","author":"Gwini","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ahj.2019.02.009_bb0085","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/01.CIR.102.25.3039","article-title":"Association of influenza vaccination and reduced risk of recurrent myocardial infarction","volume":"102","author":"Naghavi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.02.009_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000077705","article-title":"Influenza and pneumococcal vaccinations fail to prevent myocardial infarction","volume":"4","author":"Meyers","year":"2004","journal-title":"Heart Drug"},{"key":"10.1016\/j.ahj.2019.02.009_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/hs0202.102328","article-title":"Association between influenza vaccination and reduced risk of brain infarction","volume":"33","author":"Lavellee","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2019.02.009_bb0100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/152.7.674","article-title":"Influenza vaccination and the risk of primary cardiac arrest","volume":"152","author":"Siscovick","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0105","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1503\/cmaj.091891","article-title":"Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study","volume":"182","author":"Siriwardena","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ahj.2019.02.009_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/hv.2.4.2943","article-title":"Influenza vaccination and risk of incident myocardial infarction","volume":"2","author":"Heffelfinger","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ahj.2019.02.009_bb0115","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.02.009_bb0120","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/aje\/kwf073","article-title":"Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events","volume":"156","author":"Jackson","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2019.02.009_bb0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.38198.594109.AE","article-title":"Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people","volume":"329","author":"Armstrong","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2019.02.009_bb0130","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.vaccine.2006.10.015","article-title":"Impact of influenza vaccination on major cause-specific mortality","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ahj.2019.02.009_bb0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.111.071100","article-title":"Influenza vaccination and major adverse vascular events in high-risk patients","volume":"126","author":"Johnstone","year":"2012","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.ahj.2019.02.009_bb0140","first-page":"2540","article-title":"Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ahj.2019.02.009_bb0145","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ahj.2019.02.009_bb0150","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ahj.2019.02.009_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005050.pub2","article-title":"Influenza vaccines for preventing coronary heart disease","volume":"3","author":"Keller","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2019.02.009_bb0160","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ahj.2019.02.009_bb0165","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2019.02.009_bb0170","article-title":"Influenza vaccines for preventing cardiovascular disease","volume":"5","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ahj.2019.02.009_bb0175","doi-asserted-by":"crossref","first-page":"627-634.e1","DOI":"10.1016\/j.ahj.2015.07.008","article-title":"Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)","volume":"170","author":"Dokainish","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2019.02.009_bb0180","article-title":"The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis","author":"Fukuta","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ahj.2019.02.009_bb0185","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"ONTARGET Investigators","year":"2008","journal-title":"N Engl J Med"},{"issue":"9644","key":"10.1016\/j.ahj.2019.02.009_bb0190","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators","year":"2008","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.ahj.2019.02.009_bb0195","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ahj.2019.02.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001552","article-title":"Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data","volume":"10","author":"Yu","year":"2013","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.ahj.2019.02.009_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124122","article-title":"Dynamics of influenza seasonality at sub-regional levels in india and implications for vaccination timing","volume":"10","author":"Chadha","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ahj.2019.02.009_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ahj.2019.02.009_bb0215","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ahj.2019.02.009_bb0220","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ahj.2019.02.009_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2018.05.007","article-title":"High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial","volume":"202","author":"Vardeny","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2019.02.009_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2017.04.003","article-title":"Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial","volume":"189","author":"Fr\u00f6bert","year":"2017","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2019.02.009_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017","volume":"7","year":"2019","journal-title":"Lancet Respir Med"}],"updated-by":[{"DOI":"10.1016\/j.ahj.2019.11.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319300432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319300432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:16:26Z","timestamp":1558476986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319300432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":47,"alternative-id":["S0002870319300432"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.02.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ahj.2019.11.008","asserted-by":"object"}]},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}